Staff burnout in paediatric oncology: new tools to facilitate the development and evaluation of effective

S Mukherjee1, B Beresford, A Tennant

  • 1Social Policy Research Unit (SPRU), University of York, York, UK.

Insights

New scales measure work stressors and rewards for pediatric oncology staff, aiding in burnout prevention and intervention development. These validated tools support research and clinical practice in this high-stress field.

Area of Science:

  • Oncology
  • Psychology
  • Healthcare Staff Well-being

Background:

  • Pediatric oncology work is stressful, increasing burnout risk.
  • Lack of validated instruments hinders development of staff support interventions.
  • Context-specific measures are needed to assess stressors and rewards.

Purpose of the Study:

  • To develop and validate reliable research instruments for assessing work stressors and rewards in pediatric oncology.
  • To create the Work Stressors Scale - Paediatric Oncology (WSS-PO) and the Work Rewards Scale - Paediatric Oncology (WRS-PO).

Main Methods:

  • Qualitative interviews to generate an item pool (n=32).
  • Cognitive interviews (n=7) for feedback on draft measures.
  • Survey of staff (n=203) with draft and comparator measures.
  • Factor and Rasch analysis for psychometric properties.
  • Assessment of construct validity.

Main Results:

  • The Work Stressors Scale - Paediatric Oncology (WSS-PO) and Work Rewards Scale - Paediatric Oncology (WRS-PO) were developed.
  • Both scales demonstrated strong content validity.
  • Measures fulfilled classical test theory and Rasch model requirements for interval scaling.

Conclusions:

  • The WSS-PO and WRS-PO are valid and reliable tools for pediatric oncology research.
  • These scales can identify factors contributing to burnout.
  • The measures will facilitate targeted development of staff support interventions.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K